MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 20 - per page Previous page
Order by
A novel agonist that is selective for the mouse A3AR while retaining selectivity for the human receptor. More
Lead Inventor: Dr. B. Jack Longley Problem or Unmet Need: The skin is responsible for protecting the body from pathogens, temperature regulation, hair growth and vitamin production. Melanin, a brown pigment, is produced by melanocytes and taken up by... More
Lead Inventor: Charles Emala, M.D. The Challenge/ Problem/ Unmet Need: Millions of Americans suffer from asthma and chronic obstructive pulmonary disease (COPD) and bronchoconstrictive diseases have increased in frequency and associate mortality... More
These compounds can be used to treat diseases that affect the cannabinoid system and neurotransmission, such as Alzheimer, Huntington and multiple sclerosis. More
Name of principal inventor: Jeanine D'armiento Problem or Unmet Need: Chronic obstructive pulmonary disease (COPD) is a lung disease caused by cigarette use. It is the fourth leading cause of death in America; and has 11.4 million affected adults.... More
Name of the inventor: Seymour Lieberman Heteropolymers Composed of Two or More Different Monosaccharide Units; The Preparation Thereof and Their Uses as Clinical and Therapeutic Agents. Problem or Unmet Need: Synthetic forms of polysaccharides are unlike. More
Name of the inventor: Jerome Cantor A major cause of respiratory diseases, like chronic bronchitis and emphysema, is the loss elasticity in the lung. This characteristic of lung tissue is mediated in part by proteins called elastins; the lack of them... More
Name of the inventor: Charles Lawson A method of selectively decreasing pulmonary vascular resistance is described. Pulmonary vascular resistance is selectively decreased by administering endotracheally or endobronchially, an effective amount of an agent. More
Name of the inventor: Jeanine D' Armiento A method of treating or preventing a chronic obstructive pulmonary disease in a subject is described. A method for identifying a compound effective to treat or prevent a chronic obstructive pulmonary disease is... More
Name of the inventor: Jeanine D'armiento The use of metalloproteinase inhibitors in the treatment and prevention of pulmonary emphysema is described. The method involves admixing Metalloproteinase inhibitor in effective amounts with a pharmaceutically... More
Displaying 11..20 of 20 - per page Previous page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Biotech 10
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us